Tuberculosis of eye, unspecified
ICD-10 A18.50 is a billable code used to indicate a diagnosis of tuberculosis of eye, unspecified.
Tuberculosis of the eye, while a rare manifestation of extrapulmonary tuberculosis, can lead to significant ocular complications if not diagnosed and treated promptly. The condition may present with symptoms such as blurred vision, redness, pain, and photophobia. Diagnosis typically involves a thorough clinical examination, including slit-lamp examination, and may be supported by imaging studies or laboratory tests. Sputum tests and chest X-rays are often conducted to rule out pulmonary involvement, as systemic tuberculosis can precede or accompany ocular manifestations. Treatment usually involves a multi-drug regimen, including isoniazid, rifampicin, ethambutol, and pyrazinamide, tailored to the patient's specific needs and drug susceptibility patterns. Monitoring for drug resistance is crucial, as resistant strains can complicate treatment and prolong recovery. Public health implications are significant, as tuberculosis is a communicable disease; thus, contact tracing and isolation procedures may be necessary to prevent transmission. The management of tuberculosis of the eye requires a multidisciplinary approach, often involving ophthalmologists, infectious disease specialists, and public health officials.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with unexplained vision changes, ocular inflammation, or pain.
Consideration of systemic tuberculosis and its implications for ocular health.
Comprehensive history of tuberculosis exposure, treatment history, and drug susceptibility testing.
Patients with known tuberculosis history presenting with ocular symptoms.
Coordination with ophthalmology for comprehensive management.
Used for initial evaluation of a patient with suspected ocular tuberculosis.
Complete history and examination findings, including visual acuity and ocular health.
Ophthalmologists should document any systemic tuberculosis history.
Common symptoms include blurred vision, redness, pain, and sensitivity to light. Patients may also experience floaters or vision loss.
Diagnosis typically involves a clinical examination, imaging studies, and laboratory tests to confirm tuberculosis infection. A thorough history of tuberculosis exposure is also important.
Treatment usually involves a multi-drug regimen for tuberculosis, including isoniazid, rifampicin, ethambutol, and pyrazinamide. Close monitoring for drug resistance is essential.
